| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 1.683.680.049 $ | +679.738.498 $ | +14.890,5 % | 953.484.009 $ | +361.037.092 $ | +72,7 % | 290.590.510 $ | +143.326.746 $ | +93,9 % | |
| FMR LLC | 364.510.318 $ | +144.417.769 $ | +65,6 % | 220.092.549 $ | +80.528.497 $ | +57,7 % | 139.564.052 $ | +76.603.412 $ | +121,7 % |
| Venrock Adviser, LLC | 203.480.393 $ | +77.741.540 $ | +61,8 % | 125.738.853 $ | +45.964.583 $ | +57,6 % | 79.774.270 $ | +33.270.392 $ | +71,5 % |
| Fairmount Funds Management LLC | 181.743.101 $ | +69.436.610 $ | +61,8 % | 112.306.491 $ | +41.054.303 $ | +57,6 % | 71.252.188 $ | +33.452.942 $ | +88,5 % |
| BlackRock, Inc. | 173.003.617 $ | +65.723.948 $ | +61,3 % | 107.279.669 $ | +64.886.153 $ | +153,1 % | |||
| VIKING GLOBAL INVESTORS LP | 130.801.145 $ | +49.973.771 $ | +61,8 % | 80.827.374 $ | +29.546.925 $ | +57,6 % | |||
| Paradigm Biocapital Advisors LP | 113.811.500 $ | +61.971.822 $ | +119,5 % | 51.839.678 $ | |||||
| RTW INVESTMENTS, LP | 100.952.159 $ | +38.569.693 $ | +61,8 % | 62.382.466 $ | +24.967.636 $ | +66,7 % | |||
| Deep Track Capital, LP | 99.777.657 $ | +34.262.289 $ | +52,3 % | 65.515.368 $ | +14.463.930 $ | +28,3 % | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 91.214.901 $ | ||||||||
| STATE STREET CORP | 79.140.262 $ | +37.195.859 $ | +88,7 % | ||||||
| Remedium Capital Partners, LLC | 76.795.672 $ | +76.748.618 $ | +163.107,5 % | ||||||
| VANGUARD GROUP INC | 74.366.494 $ | +40.201.226 $ | +117,7 % | ||||||
| PERCEPTIVE ADVISORS LLC | 68.449.324 $ | +23.696.579 $ | +53,0 % | ||||||
| Commodore Capital LP | 53.135.067 $ | +19.423.839 $ | +57,6 % | ||||||
| 1.683.680.049 $ | +679.738.498 $ | +14.890,5 % | 953.484.009 $ | +361.037.092 $ | +72,7 % | 290.590.510 $ | +143.326.746 $ | +93,9 % | |